Naturhouse Health (XMAD:NTH) Cyclically Adjusted PS Ratio: 1.91 (As of Jul. 11, 2026) — 55% Above Median


XMAD:NTH Naturhouse Health SA XMAD:NTH
81 GF Score
Price €2.52
GF Value €1.62
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Naturhouse Health Cyclically Adjusted PS Ratio?

Naturhouse Health XMAD:NTH -1.18% 81 Cyclically Adjusted PS Ratio is 1.91 as of Jul. 11, 2026, which is 55% above its 10-year median of 1.23. GuruFocus rates XMAD:NTH with a GF Score™ of 81/100 and a GF Value™ of €1.62 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,446 Consumer Packaged Goods companies, Naturhouse Health ranks worse than 77.18% on this metric.

As of today (2026-07-11), Naturhouse Health's current share price is €2.52. Naturhouse Health's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec25 was €1.32. Naturhouse Health's Cyclically Adjusted PS Ratio for today is 1.91.

The historical rank and industry rank for Naturhouse Health's Cyclically Adjusted PS Ratio or its related term are showing as below:

XMAD:NTH' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.05   Med: 1.23   Max: 2
Current: 1.92

During the past 13 years, Naturhouse Health's highest Cyclically Adjusted PS Ratio was 2.00. The lowest was 1.05. And the median was 1.23.

XMAD:NTH's Cyclically Adjusted PS Ratio is ranked worse than
77.18% of 1446 companies
in the Consumer Packaged Goods industry
Industry Median: 0.78 vs XMAD:NTH: 1.92

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Naturhouse Health's adjusted revenue per share data of for the fiscal year that ended in Dec25 was €0.794. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €1.32 for the trailing ten years ended in Dec25.

Shiller PE for Stocks: The True Measure of Stock Valuation


Naturhouse Health  (XMAD:NTH) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Naturhouse Health Cyclically Adjusted PS Ratio Related Terms


Naturhouse Health Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Naturhouse Health's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Naturhouse Health Cyclically Adjusted PS Ratio Chart

Naturhouse Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 1.08 1.10 1.18 1.67

Naturhouse Health Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.10 0.00 1.18 0.00 1.67

XMAD:NTH vs KHC, GIS, HRL: Cyclically Adjusted PS Ratio Comparison

For the Packaged Foods subindustry, Naturhouse Health's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Naturhouse Health Cyclically Adjusted PS Ratio vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Naturhouse Health's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Naturhouse Health's Cyclically Adjusted PS Ratio falls into.


XMAD:NTH
81GF Score
Naturhouse Health SA XMAD:NTH
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Naturhouse Health Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Naturhouse Health's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=2.52/1.32
=1.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Naturhouse Health's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec25 is calculated as:

For example, Naturhouse Health's adjusted Revenue per Share data for the fiscal year that ended in Dec25 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec25 (Change)*Current CPI (Dec25)
=0.794/128.4000*128.4000
=0.794

Current CPI (Dec25) = 128.4000.

Naturhouse Health Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201612 1.630 101.842 2.055
201712 1.579 102.975 1.969
201812 1.455 104.193 1.793
201912 1.362 105.015 1.665
202012 0.919 104.456 1.130
202112 0.961 111.298 1.109
202212 0.874 117.650 0.954
202312 0.841 121.300 0.890
202412 0.824 124.753 0.848
202512 0.794 128.400 0.794

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

What does a Cyclically Adjusted PS Ratio of 1.91 mean?
Naturhouse Health (XMAD:NTH) has a Cyclically Adjusted PS Ratio of 1.91 as of Jul. 11, 2026. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Naturhouse Health and its competitors. This is 55% above median its historical median of 1.23. Over the past decade, Naturhouse Health's Cyclically Adjusted PS Ratio has ranged from 1.05 to 2.00. According to the industry distribution chart, Naturhouse Health ranks #1116 out of 1446 companies in the Consumer Packaged Goods industry, placing it in the top 77.2%.
Is Naturhouse Health's Cyclically Adjusted PS Ratio too high?
Naturhouse Health's current Cyclically Adjusted PS Ratio of 1.91 is 55% above median its 10-year median of 1.23. Over the past 10 years, this metric has ranged from a low of 1.05 to a high of 2.00. The Consumer Packaged Goods industry median Cyclically Adjusted PS Ratio is 0.78. Naturhouse Health's value of 1.91 is 144.9% above this industry median. Based on the distribution chart, Naturhouse Health ranks #1116 out of 1446 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Naturhouse Health has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Naturhouse Health's Cyclically Adjusted PS Ratio compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Naturhouse Health ranks #1116 out of 1446 companies for Cyclically Adjusted PS Ratio. This places Naturhouse Health in the lower half of its industry. The industry median Cyclically Adjusted PS Ratio is 0.78. Naturhouse Health's value of 1.91 is 144.9% above this benchmark. Historically, Naturhouse Health's own Cyclically Adjusted PS Ratio has ranged from 1.05 to 2.00 over the past decade. While the company's 10-year median is 1.23 vs. the industry median of 0.78, Naturhouse Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PS Ratio for a Consumer Packaged Goods company?
The median Cyclically Adjusted PS Ratio among Consumer Packaged Goods companies is 0.78, based on 1,446 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Naturhouse Health's current Cyclically Adjusted PS Ratio of 1.91 is 144.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PS Ratio mean?
A high Cyclically Adjusted PS Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Naturhouse Health and its competitors. For the Consumer Packaged Goods industry, the median Cyclically Adjusted PS Ratio is 0.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Naturhouse Health's current Cyclically Adjusted PS Ratio is 1.91, which is 55% above median its own 10-year median of 1.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Naturhouse Health stock overvalued right now?
Based on GuruFocus' analysis, Naturhouse Health (XMAD:NTH) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.62, compared to a current price of €2.52 — trading 55.6% above its estimated fair value. The current Cyclically Adjusted PS Ratio is 1.91, which is 55% above median its 10-year median of 1.23 and 144.9% above the Consumer Packaged Goods industry median of 0.78. Naturhouse Health's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PS Ratio calculated?
Cyclically Adjusted PS Ratio is calculated from a company's financial statements. For Naturhouse Health (XMAD:NTH), the current Cyclically Adjusted PS Ratio is 1.91 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Naturhouse Health (XMAD:NTH) Overvalued in 2026?

Based on GuruFocus' analysis, Naturhouse Health stock appears to be overvalued. The current stock price of €2.52 is trading 55.6% above its estimated GF Value™ of €1.62. GuruFocus considers Naturhouse Health to be Significantly Overvalued.

Key valuation signals for XMAD:NTH:

  • Cyclically Adjusted PS Ratio: 1.91 (55% above median its 10-year median of 1.23)
  • GF Value™: €1.62 vs. price of €2.52 (55.6% above fair value)
  • GF Score™: 81/100 with 6 warning signs
  • Industry Position: 144.9% above the Consumer Packaged Goods median (#1116 of 1446)

No single metric tells the full story. See the XMAD:NTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Naturhouse Health Business Description

Other Exchanges 0R9G:UK2NH:Germany
Address Calle Claudio Coello, 91, 4º Planta, Madrid, ESP, 28006
Naturhouse Health SA provides nutrition & weight management products. The activity of the company is the export, wholesale, and retail sales of all kinds of products related to dietetics, herbal remedies, and natural cosmetics, as well as the preparation, promotion, creation, edition, dissemination, sale, and distribution of all kinds of magazines, books, and brochures and the marketing of dietary products, herbal remedies, and natural cosmetics. This activity is mainly carried out through franchisees and its stores. The geographical segments of the company are Spain, France, Italy, Poland, and Other countries.
81GF Score

Get the complete analysis for XMAD:NTH

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.52
Price
€1.62
GF Value